Semaglutide Without a Prescription: Risks and the Legal Routes

No. semaglutide needs a prescription in the US, and no GLP-1 is sold over the counter. With a prescription, self-pay starts at $149 a month through NovoCare Pharmacy.

Prescription: Required
Lowest self-pay: $149 a month
Telehealth from, all in: $223 a month
Shortage: Resolved

Wegovy: the basics

How long it remains in the body

Its half-life is about 1 week: after 7 d, half is gone, and about 3% remains after five half-lives (35 d).

Weight loss in the main trial

STEP 1, 68 weeks: the drug group lost 14.9% of body weight, placebo 2.4%.

Costs over time

Monthly prices in US dollars include list prices and self-pay offers, each taken from the maker's price page.

Sources: FDA label (DailyMed), healthsystemtracker.org, prnewswire.com 1 2.

All the legitimate routes to semaglutide, ranked

Ways to get it, cheapest first
Route	Who it is for	What you pay
Ozempic: Novo Nordisk PAP	Household income at 200% of the federal poverty level or below	Free if approved
Ozempic: Insurance and the savings card, along with your doctor	Commercial insurance that covers it	Costs may be as low as $25 monthly, for up to 3 months
Wegovy: Insurance and the savings card, along with your doctor	Commercial insurance that covers it	As little as $25 a month
Rybelsus: Through your doctor, using insurance and the savings card	Commercial insurance that covers it	For a 1-, 2- or 3-month fill, the cost can be as little as $25
Ozempic: NovoCare Pharmacy: Ozempic pill (from 1.5 mg)	Anyone with a prescription, no insurance needed	$149 a month
Ozempic: GoodRx: GoodRx lowest price	Cash at the pharmacy counter	$149 a month
Wegovy: NovoCare Pharmacy: Wegovy pill 1.5 mg	Anyone with a prescription, no insurance needed	$149 a month
Wegovy: TrumpRx listing (pill, starting)	Self-pay only	$149 a month
Wegovy: Costco Pharmacy: member price	Cash at the pharmacy counter	$149 a month

Prices checked November 2026. Every listed price links to its source page.

Sources: Novo Nordisk pricing, NovoCare, TrumpRx, rx.costco.com.

Who qualifies

You need a prescription for any GLP-1 sold in the US. The label lists approved uses. A prescriber writes it for one of those uses:

Ozempic: It lowers blood sugar for adults with type 2 diabetes, when used with diet and exercise.
Ozempic: Heart attack, stroke and heart-related death risks drop for adults with type 2 diabetes and heart disease.
Wegovy: For adults with heart disease and obesity or overweight, it lowers the risk of heart attack, stroke or heart-related death. This applies to injection and tablet forms.
Wegovy: Adults and children aged 12 and up with obesity, or adults with overweight and a weight-related condition, can use it for lasting weight loss and keeping the weight off, with diet and activity.
Rybelsus: Used with diet and exercise, it lowers blood sugar for adults with type 2 diabetes.
Rybelsus: With it, adults with type 2 diabetes who are at high risk have a lower risk of heart attack, stroke or heart-related death.

Source: FDA label (DailyMed).

Telehealth options compared

Programs offering semaglutide through telehealth
Program	Medicine option	Medicine price	Membership	All in
WeightWatchers Med+	Wegovy pill (self-pay)	$149 a month	$74 a month	$223 a month
WeightWatchers Med+	Ozempic injectable pen (self-pay)	$199 a month	$74 a month	$273 a month
Ro	Wegovy pill, starting dose	$149 a month	$149 a month	$298 a month
Hims & Hers	Wegovy pill	$149 a month	$149 a month after first month	$298 a month
Hims & Hers	Ozempic pen	$199 a month	$149 a month after first month	$348 a month
Sesame (Success by Sesame)	Wegovy or Ozempic pen, after intro months	$349 a month	$59 a month	$408 a month
Ro	Wegovy pen, 1 mg to 2.4 mg	$349 a month	$149 a month	$498 a month
Mochi Health	Compounded semaglutide (not FDA approved)	$60 a month	$79 a month after free first month	$139 a month
Henry Meds	Compounded semaglutide taken under the tongue as tablets or drops, without FDA approval	$179 a month	Not listed	Included
Noom Med	Microdose GLP-1Rx Program (compounded) (not FDA approved)	once the first 4 weeks pass: $179 a month, billed quarterly	Not listed	Included
Noom Med	GLP-1Rx Program (compounded semaglutide) (not FDA approved)	once the first 4 weeks pass: $249 a month, billed quarterly	Not listed	Included
Found	Compounded GLP-1 plan (not FDA approved)	$99 a month	$169 a month cash	$268 a month
Henry Meds	Compounded semaglutide (weekly injection) (not FDA approved)	$297 a month	Not listed	Included

The pricing page of each program is the source of every price. We receive no payment from any of them.

Sources: weightwatchers.com, ro.co, hims.com, sesamecare.com.

Shortage status

Semaglutide: The injection shortage ended on February 21, 2025. Those older Rybelsus tablets are being discontinued, according to

Supply of semaglutide for each product
Product	FDA status	Availability
Rybelsus tablet 3 mg, 7 mg, 14 mg	To Be Discontinued	Replaced by Ozempic (semaglutide) tablets

In March 2022, it appeared on the FDA shortage list for the first time
Shortage resolved: February 21, 2025
April 22, 2025: compounding of copies at state pharmacies had to stop
Outsourcing facilities had to stop from May 22, 2025

Sources: FDA, api.fda.gov.

Scam signals

No prescription needed: any seller that skips it is not a licensed US pharmacy.
A brand price far below the manufacturer's own: the lowest self-pay price for the brand is $149 a month.
Sold as the brand but compounded: these drugs have no FDA approval, so they are neither Ozempic, Wegovy, Mounjaro nor Zepbound.
Salt forms: semaglutide sodium and semaglutide acetate differ from the active ingredient used in approved drugs.
Claims of matching the brand: misleading claims drew 30 warning letters from the FDA to telehealth companies.
Harm reports: the FDA has on file 990 adverse event reports linked to compounded semaglutide.
A monthly price that leaves out the drug: one program faced FTC action over this; see the NextMed review.

Sources: Novo Nordisk pricing, NovoCare, TrumpRx, rx.costco.com.

Find it in your state

Hims & Hers: does not reach all 50 states
Noom Med: does not reach all 50 states
NovoCare Pharmacy: its delivery network serves all 50 states, DC, Puerto Rico

Of all the factors, Medicaid rules change the route most. your route depends mostly on Medicaid rules. For weight loss, 10 state Medicaid programs cover GLP-1s now. Select your state to view its drug list and prior authorization rules:

Sources: hims.com, noom.com, NovoCare.